Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
3.15M
-
Number of holders
-
21
-
Total 13F shares, excl. options
-
199K
-
Shares change
-
+99K
-
Total reported value, excl. options
-
$711K
-
Value change
-
+$381K
-
Number of buys
-
11
-
Number of sells
-
-6
-
Price
-
$3.58
Significant Holders of GT Biopharma, Inc. - Common Stock (GTBP) as of Q2 2025
24 filings reported holding GTBP - GT Biopharma, Inc. - Common Stock as of Q2 2025.
GT Biopharma, Inc. - Common Stock (GTBP) has 21 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 199K shares
of 3.15M outstanding shares and own 6.31% of the company stock.
Largest 10 shareholders include BANK OF MONTREAL /CAN/ (92.5K shares), RENAISSANCE TECHNOLOGIES LLC (26.3K shares), GEODE CAPITAL MANAGEMENT, LLC (23.8K shares), OSAIC HOLDINGS, INC. (11.5K shares), VANGUARD GROUP INC (10.5K shares), WELLS FARGO & COMPANY/MN (10K shares), BlackRock, Inc. (9.74K shares), UBS Group AG (5.81K shares), MORGAN STANLEY (4.02K shares), and Newbridge Financial Services Group, Inc. (2.75K shares).
This table shows the top 21 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.